Enhanced nanoparticle delivery exploiting tumour-responsive formulations

Enhanced nanoparticle delivery exploiting tumour-responsive formulations

Abstract Nanoparticles can be used as drug carriers, contrast agents and radiosensitisers for the treatment of cancer. Nanoparticles can either passively accumulate within tumour sites, or be conjugated with targeting ligands to actively enable tumour deposition. With respect to passive accumulation...

Full description

Bibliographic Details
Main Authors: Lindsey A. Bennie, Helen O. McCarthy, Jonathan A. Coulter
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Cancer Nanotechnology
Subjects:
Tumour microenvironment
Nano-therapeutics
Gold nanoparticles
Cell-penetrating peptide
Cleavable stealth molecules
Nucleic acids
Online Access:http://link.springer.com/article/10.1186/s12645-018-0044-6

Internet

http://link.springer.com/article/10.1186/s12645-018-0044-6

Similar Items